CTSO

Transfer...
Symbol:
NASDAQ / Sector: Healthcare / Sub-Sector: Diagnostics & Research / Stock Type: Distressed
# of Employee: 66 / Fiscal Year End: 2016-12-31 / Stock Type: Small Core
USD / Exchange Rate: 1 at 2016-11-22 /

Cytosorbents Corp is a immunotherapy company. The Company uses blood purification to modulate inflammation with the goal of preventing or treating multiple organ failure in life-threatening illnesses.

Competitors

Competitors List | Key Matrix Details

TMO | Q | A | LH | DGX | IDXX | QGEN | PKI | DXCM | BIO | BIO.B | ICLR | BRKR | ALR | CRL | VWR | PRAH | PRXL | ALOG |

Finance Highlights

Key Ratio Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeROEFCFMarginFCFPerSharEquityPerSProfitMargContinuousNetMarginDebtEquityCurrentRat
2011-12-25Annual-1,219.10%-10,757.30%-0.60.067.40%-15,193.90%-15,193.90%.176.900
2012-12-25Annual31.40%-272.20%-0.5-1.576.20%-272.80%-272.80%-.777.706
2013-12-25Annual26.00%-153.00%-0.4-1.521.10%-193.10%-193.10%-.779.879
2014-12-25Annual-177.30%-170.50%-0.50.348.20%-226.10%-226.10%.880.592
2015-12-25Annual-117.60%-201.40%-0.40.353.80%-169.70%-169.70%2.697.309

Key Ratio Trend

ReportDatePeriodTypeROEFCFMarginFCFPerSharEquityPerSProfitMargContinuousNetMarginDebtEquityCurrentRat
AverageAnnual-17.20%-11.44%14.75%-3.07%11.62%24.94%24.94%-0.26%-32.65%
2012-12-25Annual102.58%97.47%23.93%-3,032.00%13.06%98.20%98.20%-541.48%-21.56%
2013-12-25Annual-17.20%43.79%14.75%-3.07%-72.31%29.22%29.22%-0.26%24.50%
2014-12-25Annual-781.92%-11.44%-24.43%118.27%128.44%-17.09%-17.09%212.97%-32.65%
2015-12-25Annual33.67%-18.12%20.65%19.57%11.62%24.94%24.94%206.48%-47.80%


Income Statement Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2011-12-25Annual36,078.011,760.01,044,881.0-5,481,648.0-5,481,648.06,409,41167.40%-15,193.90%-15,193.90%
2012-12-25Annual1,342,936.0319,298.0564,428.0-3,663,506.0-3,663,506.07,929,13176.20%-272.80%-272.80%
2013-12-25Annual2,422,667.01,911,565.00.0-4,677,795.0-4,677,795.09,440,76221.10%-193.10%-193.10%
2014-12-25Annual4,122,825.02,133,888.00.0-9,321,672.0-9,321,672.014,382,81348.20%-226.10%-226.10%
2015-12-25Annual4,791,616.02,212,546.00.0-8,131,738.0-8,131,738.024,885,80953.80%-169.70%-169.70%

Income Statement Trend

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
AverageAnnual70.18%11.63%0.00%-27.69%-27.69%23.71%11.62%24.94%24.94%
2012-12-25Annual3,622.31%2,615.12%-45.98%33.17%33.17%23.71%13.06%98.20%98.20%
2013-12-25Annual80.40%498.68%-100.00%-27.69%-27.69%19.06%-72.31%29.22%29.22%
2014-12-25Annual70.18%11.63%0.00%-99.27%-99.27%52.35%128.44%-17.09%-17.09%
2015-12-25Annual16.22%3.69%0.00%12.77%12.77%73.02%11.62%24.94%24.94%


Balance Sheet Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeEquityTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2011-12-25Annual318,343.01,804,199.01,697,481.01,527,949.0276,250.0.176.900
2012-12-25Annual-11,625,145.014,964,553.02,939,588.02,076,736.012,887,817.0-.777.706
2013-12-25Annual-14,265,547.018,311,282.03,486,967.03,064,932.015,246,350.0-.779.879
2014-12-25Annual3,963,183.04,505,442.07,607,006.04,505,442.00.0.880.592
2015-12-25Annual8,210,587.03,043,779.09,860,328.03,043,779.00.02.697.309

Balance Sheet Trend

ReportDatePeriodTypeEquityTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
AverageAnnual-22.71%-32.44%29.62%35.92%0.00%-0.26%-32.65%
2012-12-25Annual-3,751.77%729.43%73.17%35.92%4,565.27%-541.48%-21.56%
2013-12-25Annual-22.71%22.36%18.62%47.58%18.30%-0.26%24.50%
2014-12-25Annual127.78%-75.40%118.16%47.00%-100.00%212.97%-32.65%
2015-12-25Annual107.17%-32.44%29.62%-32.44%0.00%206.48%-47.80%


Cash Flow Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeOperatingCCAPEXFreeCashFlInvestmentFinancialF
2011-12-25Annual-3,828,527.0-52,490.0-3,881,017.0-52,490.05,141.0
2012-12-25Annual-3,616,447.0-38,806.0-3,655,253.0-38,806.010,605.0
2013-12-25Annual-3,489,320.0-216,356.0-3,705,676.0-216,356.02,220,161.0
2014-12-25Annual-6,661,193.0-367,322.0-7,028,515.0-2,311,869.09,860,656.0
2015-12-25Annual-9,008,934.0-643,447.0-9,652,381.0-890,900.011,640,242.0

Cash Flow Trend

ReportDatePeriodTypeOperatingCCAPEXFreeCashFlInvestmentFinancialF
AverageAnnual-35.25%-75.17%-37.33%-457.53%106.28%
2012-12-25Annual5.54%26.07%5.82%26.07%106.28%
2013-12-25Annual3.52%-457.53%-1.38%-457.53%20,835.04%
2014-12-25Annual-90.90%-69.78%-89.67%-968.55%344.14%
2015-12-25Annual-35.25%-75.17%-37.33%61.46%18.05%



Finance Detail

Income Statement Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

0: years2006-122007-122008-122009-122010-122011-122012-122013-122014-122015-12
1: Revenue00000360781342936242266741228254791616
2: Cost of revenue0000011760319298191156521338882212546
3: Gross profit0000024318102363851110219889372579070
4: Operating expenses29643113066630324421230273622824019446108545144725224333926772911882729
5: Research and development1112804141550919834831961960175737028882452532489173893824317593871069
6: Sales, General and administrative1851507165112112607291065402106664915728401981983348539568359708011660
7: Restructuring, merger and acquisition0000000000
8: Other operating expenses0000000000
9: Operating income-2964311-3066630-3244212-3027362-2824019-4436767-3490834-4713231-7278792-9303659
10: Interest Expense47388770222078142848461044881564428000
11: Other income (expense)7703188306663006071008581773000-422843-2428522847315
12: Income before taxes00-326641930355042908865-5481648-4055262-5136074-9707314-8456344
13: Provision for income taxes00-24852929878900-391756-458279-385642-324606
14: Other income-7671580-33507540-5473430-581773000000
15: Net income from continuing operations-7671580-3350754-3017890-2736715-2908865-5481648-3663506-4677795-9321672-8131738
16: Net income from discontinuing ops0000000000
17: Extraordinary items0000000000
18: Cumulative effect of accounting changes0000000000
19: Other0000000000
20: Net income-7671580-3350754-3017890-2736715-2908865-5481648-3663506-4677795-9321672-8131738
21: Preferred dividend775536760872905382704325217746430870442511412239552092666730
22: Net income available to common shareholders-8447116-4111626-3923272-3441040-5086329-8568692-6174918-7073315-18588345-8131738
23: Earnings per share0000000000
24: Basic-14-4.25-4-2-1.25-1.25-0.75-0.75-1.29-0.33
25: Diluted-14-4.25-4-2-1.25-1.25-0.75-0.75-1.29-0.33
26: Weighted average shares outstanding0000000000
27: Basic5982429939421004855166374439237906409411792913194407621438281324885809
28: Diluted5982429939421004855166374439237906409411792913194407621438281324885809
29: EBITDA-1708785-2876190-314051130953413011515-4397617-3436228-4648881-7213245-9190690
30: Total operating expenses29643113066630324421230273622824019446108545144725224333926772911882729


Balance Sheet Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

0: years2006-122007-122008-122009-122010-122011-122012-122013-122014-122015-12
1: Assets3445049802572338718522384801811926212254233394084045735846862511254366
2: Current assets289801841229530658181964719140020516974812939588348696776070069860328
3: Cash287313821161329488151595628105566911866531729344218303055498277508851
4: Cash and cash equivalents287313821161327492081595628105566911866531729344218303036052805316851
5: Short-term investments001996070000019445472192k
6: Receivables000003607851779453017819151648869
7: Inventories000004310226823722456085375661190681
8: Deferred income taxes0000000000
9: Prepaid expenses2488020068211700336909134453643728476093605312700462511927
10: Other current assets0000000000
11: Non-current assets5470313902773213672737614117214250613998205587688616191394038
12: Property, plant and equipment3035601444575205718853144146155067145600144393245821557289
13: Gross property, plant and equipment2302810232423723242372330647246031824949902514840254574727024573098263
14: Accumulated Depreciation-1999250-2179780-2272180-2311794-2316172-2339923-2369240-2401354-2456636-2540974
15: Equity and other investments0000000000
16: Goodwill0000000000
17: Intangible assets0191926202676198514211181269994207267360481557528771795
18: Deferred income taxes0000000000
19: Prepaid pension benefit0000000000
20: Other long-term assets24347153894666345639456394046953538945827064954
21: Liabilities and stockholders' equity3445049802572338718522384801811926212254233394084045735846862511254366
22: Liabilities1082044906868102770497076522965071804199149645531831128245054423043779
23: Current liabilities1082044906868977704970765121911915279492076736306493245054423043779
24: Short-term debt00000294323926225164435600
25: Capital leases0000000000
26: Accounts payable942265775342885465852167817701675160800670786517698307684633
27: Deferred income taxes0000000000
28: Taxes payable000000006474522592
29: Accrued liabilities13977913152692239118598401418558466349841361700730139633190
30: Deferred revenues00000002723593083330k
31: Other current liabilities0000000029814181673364
32: Non-current liabilities0050k01077388276250128878171524635000
33: Long-term debt0050k010773882762500000
34: Capital leases0000000000
35: Deferred taxes liabilities0000000000
36: Accrued liabilities0000000000
37: Deferred revenues0000000000
38: Pensions and other benefits0000000000
39: Minority interest0000000000
40: Other long-term liabilities000000128878171524635000
41: Stockholders' equity2363005-10429623594811267715-484581318343-11625145-1426554739631838210587
42: Preferred stock7403801988486325588715121594176000
43: Common stock246292504525264663751228381776262149682513202330525397
44: Other Equity0000000000
45: Additional paid-in capital6975755671400849777868508009753683375544926967478690341591343135128106297140126731
46: Retained earnings-67426583-71538209-75461481-78902521-83988850-92557542-98732460-105805775-124394120-132525858
47: Treasury stock0000000000
48: Accumulated other comprehensive income000000-12662-55987227701584317
49: Total assets3445049802572338718522384801811926212254233394084045735846862511254366
50: Total liabilities and stockholders' equity3445049802572338718522384801811926212254233394084045735846862511254366
51: Total cash287313821161329488151595628105566911866531729344218303055498277508851
52: Total current assets289801841229530658181964719140020516974812939588348696776070069860328
53: Net property, plant and equipment3035601444575205718853144146155067145600144393245821557289
54: Total non-current assets5470313902773213672737614117214250613998205587688616191394038
55: Total current liabilities1082044906868977704970765121911915279492076736306493245054423043779
56: Total non-current liabilities0050k01077388276250128878171524635000
57: Total liabilities1082044906868102770497076522965071804199149645531831128245054423043779
58: Total stockholders' equity2363005-10429623594811267715-484581318343-11625145-1426554739631838210587


Cash Flow Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

0: years2006-122007-122008-122009-122010-122011-122012-122013-122014-122015-12
1: Cash Flows From Operating Activities-2849182-2627839-2365349-2674613-2477258-3828527-3616447-3489320-6661193-9008934
2: Net income-7671580-3350754-3017890-2736715-2908865-5481648-3663506-4677795-9321672-8131738
3: Depreciation & amortization1255526190440103701516951780439150546066435065547112969
4: Amortization of debt discount/premium and issuance costs0000489439454344713523112481986440
5: Investment/asset impairment charges0000000000
6: Investments losses (gains)0000000000
7: Deferred income taxes0000000000
8: (Gain) Loss from discontinued operations0000000000
9: Extraordinary items0000000000
10: Cumulative effect of accounting change0000000000
11: Stock based compensation0000006312865468695841382284
12: Accounts receivable00000-36078-15701000
13: Inventory00000-431022-251350436764-303129-632535
14: Prepaid expenses-5619-17580283679-25208824555300808-432365-129219-108153178107
15: Accounts payable000666000000
16: Accrued liabilities0000000000
17: Interest payable0000000000
18: Income taxes payable0000000000
19: Other working capital68903-1421655809710239190980-30706157389-17073-19097540834
20: Other non-cash items350358885044240706425159014932586553504569372302704-958855
21: Cash Flows From Investing Activities-64863-33686-221659185279-165449-52490-38806-216356-2311869-890900
22: Investments in property, plant, and equipment-64863-33686-22052-6411-139356-34672-19850-38684-153157-403608
23: Property, plant, and equipment reductions0000000000
24: Acquisitions, net0000000000
25: Purchases of investments00-39360700000-6689547-5678k
26: Sales/Maturities of investments00194k19960700004745k5430547
27: Investments in technologies0000000000
28: Sales of technologies0000000000
29: Purchases of intangibles00-22052-7917-26093-17818-18956-177672-214165-239839
30: Sales of intangibles0000000000
31: Other investing activities00220520000000
32: Cash Flows From Financing Activities507992705124603133575421027484012001421060642026871001690611640242
33: Debt issued00225k013352501250k700k1843k00
34: Debt repayment0000000000
35: Preferred stock issued0048996030000000
36: Preferred stock repaid0000000000
37: Warrant issued00000001395261562500
38: Common stock issued50799270007674982756860350k000
39: Common stock repurchased0000000000
40: Excess tax benefit from stock based compensation0000000000
41: Dividend paid0000000000
42: Dividend payable0000000000
43: Other financing activities000133575405141106052220161986065611640242
44: Effect of exchange rate changes000000-12662-43325378406-28837
45: Net change in cash2165882-26615252537595-1153580-53995913098454269145368614222501711571
46: Cash at beginning of period70725628731382116132749208159562810556691186653172934421830303605280
47: Cash at end of period287313821161327492081595628105566911866531729344218303036052805316851
48: Free Cash Flow0000000000
49: Operating cash flow-2849182-2627839-2365349-2674613-2477258-3828527-3616447-3489320-6661193-9008934
50: Capital expenditure-64863-33686-22052-14328-165449-52490-38806-216356-367322-643447
51: Free cash flow-2914045-2661525-2387401-2688941-2642707-3881017-3655253-3705676-7028515-9652381
52: Net cash provided by operating activities-2849182-2627839-2365349-2674613-2477258-3828527-3616447-3489320-6661193-9008934
53: Net cash used for investing activities-64863-33686-221659185279-165449-52490-38806-216356-2311869-890900
54: Net cash provided by (used for) financing activities507992705124603133575421027484012001421060642026871001690611640242



Note